Delivery Order SPE2DB22D1202-SPE2DB25FVGU9
- Not listed
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The order is for 4,565,470,262 units of Gabapentin 600 mg tablets and has a ceiling value of $1,474.56. It is a firm fixed price contract type with an ultimate completion date of August 16, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The company holds several Indefinite Delivery Contracts...
- The Defense Logistics Agency awarded a $2,858.01 delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of 500 tablets of Gabapentin 800 mg. This is a firm fixed-price, non-set-aside contract with a completion date of July 23, 2025, and performance at the vendor's Conshohocken, Pennsylvania facility. The delivery order represents a small-value pharmaceutical procurement supporting federal medical supply requirements, consistent with routine military healthcare operations....
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4,565,924,465 Gabapentin 800 mg tablets. The firm-fixed price contract, with a ceiling value of $1,923.48, has an ultimate completion date of September 25, 2024. AmerisourceBergen, a major pharmaceutical distributor, is supplying these prescription medications to support military treatment facilities and other federal healthcare providers. The contract is not designated as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,556.03 firm fixed-price delivery order is for the supply of 4,566,181,525 units of Gabapentin 800 mg tablets, with a period of performance through October 23, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, serving as a primary vehicle...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The contract is a Delivery Order valued at $1,111.69 for the supply of 300 mg Gabapentin capsules. It is a Firm Fixed Price contract with a performance period through July 11, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
- Amerisourcebergen Drug Corporation, operating as Amerisourcebergen, has been awarded a firm fixed price delivery order valued at $23,050 by the Defense Logistics Agency Troop Support Medical to supply 600 mg gabapentin tablets. The single delivery order is for 90 tablets to be shipped to a location in Conshohocken, Pennsylvania, with performance required by August 1, 2023. No major subcontractors or set aside designations were indicated. The Defense Logistics Agency Troop Support Medical...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $1,091.13 issued by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of 4564677665 GABAPENTIN 600 MG TABLET 500S, a pharmaceutical product, with a period of performance through May 22, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, valued at $1,693.44, was issued by the Defense Logistics Agency (DLA) under a Delivery Order contract. The contract is for the supply of Gabapentin 300 mg capsules, a pharmaceutical product used to treat various neurological conditions. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 held by Amerisourcebergen with the DLA Troop Support Medical, which...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,905.51, is for the delivery of 4,567,873,176 units of Gabapentin 600 mg tablets in lots of 100. The contract is not designated as a set-aside and is considered an open competition award. It is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $295.05 delivery order by the Defense Logistics Agency to provide 4561847749 units of Gabapentin 250 mg/5 ml solution in 470ml bottles. The single day order is for pharmaceutical products to support the Defense Logistics Agency's medical supply needs. As the prime contractor, Amerisourcebergen Drug Corporation will fulfill the order from its facility in Conshohocken, Pennsylvania on a firm fixed...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB25FVGU9Delivery Order
AmerisourceBergen Drug Corp was awarded a delivery order valued at $2,194.37 by the Defense Logistics Agency for 500 tablets of Gabapentin 600 mg. The contract was competitively awarded on August 7, 2025, with an ultimate completion date of August 8, 2025, and is structured as a firm fixed-price delivery order with no set-aside designation. Performance will be executed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceuticals, medical supplies, and specialty medications to support military healthcare programs worldwide. The DLA Troop Support Medical Supply Chain relies on AmerisourceBergen as a critical vendor for federal medical procurement, particularly serving the Defense Health Agency and other government healthcare systems through flexible contract vehicles designed to meet diverse pharmaceutical needs across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 8/7/25 |